RxDoctor Payments Data

Ian Tingey

Oral and Maxillofacial Surgery · Farmington, CTNPI 1427075381

Payments from drug & device makers

What this record shows

The money is spread across several categories — other (58.5%), food and beverage and entertainment — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Kls-martin L.p. at 58.5% of the total. Reporting peaked in 2024 at $1,366 and has fallen 96.3% since, to $50 in 2025.

$2,334in general payments, 2019–2025

Across 16 payments — averaging $145.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kls-martin L.p.$1K
  • Nobel Biocare USA$257
  • Keystone Dental Inc.$190
  • Straumann USA LLC$161
  • Zimmer Biomet$146
  • Geistlich Pharma, North America, Inc.$84
  • plus $130 from 3 others

What the payments were for

  • Food & beverage$77833%
  • Entertainment$1908%
  • Other$1,36659%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,334 in reported general payments places this provider in the 80th percentile of 101 oral and maxillofacial surgery providers in Connecticut.

See all oral and maxillofacial surgery providers in Connecticut

Medicare billing

Part B allowed, 2024
$9,917
Medicare patients
30
Services billed
53

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Chlorhexidine Gluconate193$656
Amoxicillin184$448
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen191$374
Azithromycin27$106
Dexamethasone16$81
Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen18$55

Paid to pharmacies, not to this prescriber.

Other oral and maxillofacial surgery in Farmington

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →